Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes

[1] Buse JB(2007)Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association Circulation 115 114-126

[2] Ginsberg HN(2003)Type 2 diabetes, cardiovascular risk, and the link to insulin resistance Clin Ther 25 B4-31

[3] Bakris GL(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-986

[4] Clark NG(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412

[5] Costa F(2002)Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus Clin Chem 48 436-472

[6] Eckel R(2006)How should HbA Diabetologia 49 7-10

[7] Fonseca V(1998) measurements be reported? Lancet 352 837-853

[8] Gerstein HC(1996)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Diabetologia 39 1577-1583

[9] Grundy S(2008)Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Interventional Study, 11-year follow-up Diabetes Care 31 S150-154

[10] Nesto RW(2008)Glycemic variability: should we and can we prevent it? Diabetes 57 1349-1354

[1] Buse JB(2007)Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association Circulation 115 114-126

[2] Ginsberg HN(2003)Type 2 diabetes, cardiovascular risk, and the link to insulin resistance Clin Ther 25 B4-31

[3] Bakris GL(1993)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977-986

[4] Clark NG(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412

[5] Costa F(2002)Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus Clin Chem 48 436-472

[6] Eckel R(2006)How should HbA Diabetologia 49 7-10

[7] Fonseca V(1998) measurements be reported? Lancet 352 837-853

[8] Gerstein HC(1996)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Diabetologia 39 1577-1583

[9] Grundy S(2008)Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Interventional Study, 11-year follow-up Diabetes Care 31 S150-154

[10] Nesto RW(2008)Glycemic variability: should we and can we prevent it? Diabetes 57 1349-1354